(38) demonstrated the role of the CREB/EP300/GPX4 axis in the therapy of lung cancer using western blotting (IB), immunohistochemistry (IHC), and enzyme-linked immunosorbent assay (ELISA). This evidence concerns the gene GPX4 and lung cancer.